Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMLX Amylyx Pharmaceuticals, Inc.

交易中 04-23 12:11:48 EDT

1.96

-0.02

-1.01%

最高2.02	最低1.96	成交量54.87万
今开1.99	昨收1.98	日振幅3.03%
总市值1.33亿	流通市值9,980万	总股本6,778万
成交额109.50万	换手率1.08%	流通股本5,092万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals, Inc.","latestPrice":1.96,"timestamp":1713888691001,"preClose":1.98,"halted":0,"volume":548666,"delay":0,"floatShares":50920071,"shares":67782139,"eps":0.7,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"04-23 12:11:48 EDT","open":1.99,"high":2.02,"low":1.96,"amount":1094995.2863726001,"amplitude":0.030303,"askPrice":1.97,"askSize":2511,"bidPrice":1.96,"bidSize":3540,"shortable":3,"etf":0,"ttmEps":0.7,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1713902400000},"adr":0,"listingDate":1641531600000,"adjPreClose":1.98,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":1.98,"latestTime":"09:28 EDT","volume":2932,"amount":5874.4549256,"timestamp":1713878880079},"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.98,"latestTime":"19:42 EDT","volume":35376,"amount":70048.9303,"timestamp":1713829354785},"volumeRatio":0.735018},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2428086662","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428086662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428086662?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:28","pubTimestamp":1713547692,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时28分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.05%。截至发稿，该股报1.88美元/股，成交量88.9055万股，换手率1.31%，振幅6.82%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420012812861e780a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420012812861e780a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427887259","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427887259","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427887259?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:42","pubTimestamp":1713206576,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时42分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.12%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602425687e80864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041602425687e80864&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426295885","title":"Amylyx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426295885","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426295885?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:36","pubTimestamp":1712856963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时36分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.28%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为775.83%、578.37%、512.11%，振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation，振幅分别为53.23%、52.42%、50.92%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041201360487e7fae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041201360487e7fae3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426415852","title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426415852","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426415852?lang=zh_cn&edition=full","pubTime":"2024-04-10 22:48","pubTimestamp":1712760525,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日22时48分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1704.85%、74.64%、34.50%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.，振幅分别为72.57%、52.44%、31.96%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410224846861e4ad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410224846861e4ad9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425918344","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425918344","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425918344?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:45","pubTimestamp":1712583906,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时45分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.34%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Longeveron Inc.、Apollomics Inc C/Wts 01/04/2028 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为588.23%、582.66%、53.22%，振幅较大的相关个股有Longeveron Inc.、泰坦制药、Cns Pharmaceuticals, Inc.，振幅分别为54.90%、19.27%、18.10%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214506861e3ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214506861e3ef4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425760546","title":"3期临床未达终点 Amylyx(AMLX.US)渐冻症药主动撤市","url":"https://stock-news.laohu8.com/highlight/detail?id=2425760546","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425760546?lang=zh_cn&edition=full","pubTime":"2024-04-06 07:45","pubTimestamp":1712360727,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月4日，Amylyx Pharmaceuticals宣布与美国食品和药物管理局和加拿大卫生部达成协议，主动撤市治疗肌萎缩侧索硬化成人患者的药物Relyvrio。此外，Amylyx还宣布将进行重组，将公司的财务资源集中在即将到来的临床里程碑上，该公司将裁员约70%。随着此次计划的开展，Amylyx预计现金跑道将延长至2026年，将专注于关键里程碑包括HELIOS 、ORION 的临床数据，以及AMX0114治疗ALS的计划试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098944.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424399158","title":"BUZZ-Amylyx 制药公司因裁员而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2424399158","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424399158?lang=zh_cn&edition=full","pubTime":"2024-04-04 20:53","pubTimestamp":1712235228,"startTime":"0","endTime":"0","summary":"    4月4日 - ** 制药商Amylyx Pharmaceuticals的  股价盘前上涨3%至2.71美元 ** 该公司将把 ，减少约70%的员工，截至2023年底，该公司共有384名全职员工。** 补充说，该公司将为希望继续接受治疗的患者免费提供这种疗法 ** 公司将继续开发治疗遗传性疾病沃尔夫拉姆综合征的主要候选药物AMX0035和治疗渐冻人症的其他药物AMX0114 ** 截至收盘，股价下跌 82.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424398475","title":"更新版 1-Amylyx Pharma 将从美国和加拿大市场撤下 ALS 药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2424398475","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424398475?lang=zh_cn&edition=full","pubTime":"2024-04-04 19:52","pubTimestamp":1712231574,"startTime":"0","endTime":"0","summary":"     路透社4月4日 - Amylyx Pharmaceuticals   将从美国和加拿大撤出其肌萎缩性脊髓侧索硬化症 药物，这是该公司在市场上的唯一产品，因为该疗法在一项关键的后期试验中失败了。为何重要在患者团体的游说下，这款名为 Relyvrio 的 ALS 药物于 2022 年获得批准，患者团体指出，治疗这种可能致命的疾病的选择有限。作为重组的一部分，Amylyx 预计将产生约 1900 万美元的费用，预计将在第三季度末完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424362042","title":"Amylyx 制药公司将从美国和加拿大市场撤下 ALS 药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2424362042","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424362042?lang=zh_cn&edition=full","pubTime":"2024-04-04 19:07","pubTimestamp":1712228848,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月4日 - Amylyx Pharmaceuticals   周四表示，它将从美国和加拿大市场撤回其肌萎缩性脊髓侧索硬化症(ALS) 药物，因为该疗法在一项关键的后期试验中失败了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424040722","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.54%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424040722","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424040722?lang=zh_cn&edition=full","pubTime":"2024-04-02 23:16","pubTimestamp":1712070995,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日23时16分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.54%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.66%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402231635861e30ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402231635861e30ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422158609","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.07%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422158609?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:32","pubTimestamp":1711549960,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时32分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.07%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272232407a4f8aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272232407a4f8aac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421824470","title":"Amylyx Pharmaceuticals, Inc.盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421824470","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421824470?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:55","pubTimestamp":1711137345,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时55分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.23%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035545861e080f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323035545861e080f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420747489","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420747489?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:34","pubTimestamp":1710768864,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时34分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.56%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213424791b34fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213424791b34fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607615","title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607615","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607615?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:39","pubTimestamp":1710423578,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时39分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.27%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213939861de3c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213939861de3c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537494","title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537494","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537494?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:32","pubTimestamp":1710250331,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.26%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm  Plc涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为150.20%、127.39%、27.47%，振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited，振幅分别为34.35%、13.07%、12.26%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418953482","title":"BUZZ-ALS 药物在关键研究中失败后，分析师下调了 Amylyx 的股票评级，导致其股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2418953482","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418953482?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:07","pubTimestamp":1710248837,"startTime":"0","endTime":"0","summary":"    3月12日 - ** 制药商Amylyx Pharmaceuticals   股价盘前下跌5.8%至3.58美元** AMLX股价周五创下历史新低， ，此前该公司表示，由于在一项晚期试验中未能减缓疾病进展，它正在考虑从市场上撤回其肌萎缩性脊髓侧索硬化症 治疗药物Relyvrio。** 自上周五以来，至少有两家券商下调了该公司的股票评级** H.C. Wainwright 将预期评级从 42 美元下调至 8 美元** 鉴于试验结果，\"即将在第二季度 \"取消 Relyvrio 在 ALS 中的应用--券商** 截至上次收盘，股价在过去 12 个月中下跌了 87.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418636397","title":"Amylyx Pharmaceuticals, Inc.盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418636397","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418636397?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:51","pubTimestamp":1710165096,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时51分，Amylyx Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.06%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311215136861dd16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311215136861dd16c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417006302","title":"BUZZ-已获批准的 ALS 药物在确证研究中失败，Amylyx 再创新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2417006302","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417006302?lang=zh_cn&edition=full","pubTime":"2024-03-08 23:21","pubTimestamp":1709911315,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (更新)    3月8日 - ** 制药公司Amylyx Pharmaceuticals   股价下跌85.8%，跌至2.70美元的历史最低点。** 如果跌势持续，股价将创下自2022年上市以来的最大单日跌幅** 该公司表示， (link)，其已获批的 ALS 药物（在美国名为 Relyvrio，在加拿大名为 Albrioza）未能达到晚期确证试验的主要目标。** AMLX 公司表示，它将分享该药物的计划，其中可能包括自愿从市场上撤出该药物** 过去 12 个月股价下跌 91.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417057847","title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘股价大跌84.34%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417057847","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417057847?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:31","pubTimestamp":1709908319,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时31分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下挫84.34%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Cero Therapeutics Holdings, Inc.涨幅较大，Scisparc Ltd.、Psyence Biomedical Ltd.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为202.48%、199.46%、173.64%，振幅较大的相关个股有Psyence Biomedical Ltd.、In8Bio, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为34.25%、17.21%、14.90%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩侧索硬化症和其他神经退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231598765ca81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231598765ca81&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417905289","title":"嗡嗡声--美国股票走势-通用电气、Ainos、Velo3D","url":"https://stock-news.laohu8.com/highlight/detail?id=2417905289","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417905289?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:14","pubTimestamp":1709907283,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      3月8日 - 在华尔街隔夜大幅反弹之后，美国股指期货周五下滑，因为投资者在为一份可能决定利率走向的重要劳动力市场报告做准备。美东时间9:01，道指电子盘  上涨0.03%，报38837点。标准普尔500指数小型股  上涨0.27%，报5175.75点；纳斯达克100指数小型股  上涨0.26%，报18363点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":-0.0435},{"period":"1month","weight":-0.2774},{"period":"3month","weight":-0.8645},{"period":"6month","weight":-0.8771},{"period":"1year","weight":-0.9362},{"period":"ytd","weight":-0.8655}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0412},{"period":"3month","weight":0.0306},{"period":"6month","weight":0.1968},{"period":"1year","weight":0.2123},{"period":"ytd","weight":0.0514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amylyx Pharmaceuticals, Inc.于2014年1月10日根据特拉华州法律成立。他们的任务是开发治疗方法，通过让神经元存活来改变肌萎缩侧索硬化症和一系列神经退行性疾病的治疗模式。该公司正在寻求其候选产品AMX0035的商业化，他们认为这是第一个在ALS患者的大规模临床试验中显示出功能和生存益处的候选药物。该公司相信AMX0035有潜力成为一种基础疗法，这意味着它可以单独使用或与其他疗法结合使用，以改变广泛的神经退行性疾病的治疗模式。","exchange":"NASDAQ","name":"Amylyx Pharmaceuticals, Inc.","nameEN":"Amylyx Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amylyx Pharmaceuticals, Inc.,AMLX,Amylyx Pharmaceuticals, Inc.股票,Amylyx Pharmaceuticals, Inc.股票老虎,Amylyx Pharmaceuticals, Inc.股票老虎国际,Amylyx Pharmaceuticals, Inc.行情,Amylyx Pharmaceuticals, Inc.股票行情,Amylyx Pharmaceuticals, Inc.股价,Amylyx Pharmaceuticals, Inc.股市,Amylyx Pharmaceuticals, Inc.股票价格,Amylyx Pharmaceuticals, Inc.股票交易,Amylyx Pharmaceuticals, Inc.股票购买,Amylyx Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals, Inc.(AMLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amylyx Pharmaceuticals, Inc.(AMLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}